Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 1008-1020

  Whitman, Stewart C ^a   Sawyez, Cynthia G ^a   Miller, David B ^a   Wolfe, Bernard M ^a   Huff, Murray W ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Foam cells; Lipoprotein lipase; Macrophages; Oxidation; Scavenger receptor; Type IV hyperlipoproteinemia; VLDL remnants

Indexed keywords

CHOLESTEROL ESTER; LIPOPROTEIN LIPASE; SCAVENGER; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CATALYSIS; CELL CULTURE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FOAM CELL; HUMAN; HYPERTRIGLYCERIDEMIA; MACROPHAGE; MACROPHAGE FUNCTION; OXIDATION; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELL LINE; CHOLESTEROL ESTERS; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MACROPHAGES; MICE; MILK;

EID: 0031899996     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Schaffner, T., K. Taylor, E. J. Bartucci, K. Fischer-Dzoga, J. H. Beeson, S. Glagov, and R. W. Wissler. 1980. Arterial foam cells with distinctive immunomorphic and histochemical features of macrophages. Am. J. Pathol. 100: 57-80.
2. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181-190.
3. Fogelman, A. M., I. Shechter, J. Seager, M. Hokom, J. S. Child and P. A. Edwards. 1980. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA. 77: 2214-2218.
4. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78: 6499-6503.
5. Hoff, H. F., and J. A. O'Neil. 1991. Oxidation of LDL: role in atherogenesis. Klin. Wochenschr. 69: 1032-1038.
6. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
7. Huff, M. W., A. J. Evans, C. G. Sawyez, B. M. Wolfe, and P. J. Nestel. 1991. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins: a comparison of VLDL from subjects with Types III, IV and V hyperlipoproteinemia. Arterioscler. Thromb. 11: 221-233.
8. Evans, A. J., C. G. Sawyez, B. M. Wolfe, P. W. Connelly, G. F. Maguire, and M.W. Huff. 1993. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density subfractions occurs by different mechanisms. J. Lipid Res. 34: 703-717.
9. Bates, S. R., B. A. Coughlin, T. Mazzone, J. Borensztajn, and G. S. Getz. 1987. Apoprotein E mediates the interaction of beta-VLDL with macrophages. J. Lipid Res. 28: 787-797.
10. Ishibashi, S., N. Yamada, H. Shimano, N. Mori, H. Mokuno, T. Gotohda, M. Kawakami, T. Murase, and F. Takaku. 1990. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J. Biol. Chem. 265: 3040-3047.
11. Granot, E., and S. Eisenberg. 1990. ApoE-3-specific metabolism of human plasma very low density lipoproteins in cultured J-774 macrophages. J. Lipid Res. 31: 2133-2139.
12. Gianturco, S. H., W. A. Bradley, A. M. Gotto, J. D. Morrisett, and D. L. Peavy. 1982. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis in mouse peritoneal macrophages. J. Clin. Invest. 70: 168-178.
13. Lindqvist, P., A. Ostlund-Lindqvist, J. L. Witztum, D. Steinberg, and J. A. Little. 1983. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J. Biol. Chem. 258: 9086-9092.
14. Sacks, F. M., and J. L. Breslow. 1987. Very low density lipoproteins stimulate cholesterol ester formation in U937 macrophages: heterogeneity and biologic variation among normal humans. Arteriosclerosis. 7: 35-46.
15. Sane, T., and E. A. Nikkila. 1988. Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Arteriosclerosis. 8: 217-226.
16. Grundy, S. M., H. Y. I. Mok, L. Zech, D. Steinberg, and M. Berman. 1979. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J. Clin. Invest. 63: 1274-1283.
17. Breslow, J. L., and M. Dammerman. 1995. Genetic basis of lipoprotein disorders. Circulation. 91: 505-512.
18. Barbir, M., D. Wile, I. Trayner, V. R. Aber, and G. R. Thompson. 1988. High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease. Br. Heart J. 60: 397-403.
19. Carlson, L. A., and L. E. Bottiger. 1985. Risk factors for heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med. Scand. 218: 207-211.
20. Castelli, W. P. 1986. The triglyceride issue: a view from Framingham. Am. Heart J. 112: 432-437.
21. Huff, M. W., W. C. Breckenridge, W. L. Strong, and B. M. Wolfe. 1988. Metabolism of apolipoproteins C-II, C-III and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis. Arteriosclerosis. 8: 471-479.
22. Shepherd, J., and C. J. Packard. 1987. Metabolic heterogeneity in very low density lipoproteins. Am. Heart J. 113: 503-508.
23. Reardon, M. F., N. H. Fidge, and P. J. Nestel. 1978. Catabolism of very low density lipoprotein apoprotein B in man. J. Clin. Invest. 61: 850-860.
24. Packard, C. J., A. Munro, R. Lorimer, A. M. Gotto, and J. Shepherd. 1984. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J. Clin. Invest. 74: 2178-2192.
25. Havel, R. J., and R. L. Hamilton. 1988. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology. 8: 1689-1704.
26. Yla-Herttuala, S., O. Jaakkola, C. Ehnholm, M. J. Tikkanen, T. Solakivi, T. Sarkioja, and T. Nikkari. 1988. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J. Lipid Res. 29: 563-572.
27. Rapp, J. H., A. Lespine, R. L. Hamilton, N. Colyvas, A. H. Chaumeton, J. Tweedie-Hardman, L. Kotite, S. T. Kunitake, R. J. Havel, and J. P. Kane. 1994. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaques. Arterioscler. Thromb. 14: 1767-1774.
28. Schaefer, E. J., and R. I. Levy. 1985. Pathogenesis and management of lipoprotein disorders. N. Engl. J. Med. 312: 1300-1310.
29. Bouthilleir, D. C. F., C. F. Sing, and J. Davignon. 1983. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J. Lipid Res. 24: 1060-1069.
30. Evans, A. J., M. W. Huff, and B. M. Wolfe. 1989. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men. J. Lipid Res. 30: 1691-1701.
31. Evans, A. J., C. G. Sawyez, B. M. Wolfe, and M. W. Huff. 1992. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. J. Biol. Chem. 267: 10743-10751.
32. Markwell, M. A. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
33. Miller, N. J., C. Rice-Evans, M. J. Davies, V. Gopinatham, and A. Milner. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84: 407-412.
34. Socorro, L., and R. L. Jackson. 1985. Monoclonal antibodies to bovine milk lipoprotein lipase. J. Biol. Chem. 260: 6324-6328.
35. Huff, M. W., A. J. Evans, B. M. Wolfe, P. W. Connelly, G. F. Maguire, and W. L. P. Strong. 1990. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject. J. Lipid Res. 31: 385-396.
36. Steinbrecher, U. P., J. L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis. 7: 135-143.
37. Kleinveld, H. A., H. L. M. Hak-Lemmers, A. F. H. Stalenhoef, and P. N. M. Demacker. 1992. Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low density lipoprotein. Clin. Chem. 38: 2066-2072.
38. Huff, M. W., and D. E. Telford. 1984. Characterization and metabolic fate of two very low density lipoprotein subfractions separated by heparin-Sepharose chromatography. Biochim. Biophys. Acta. 796: 251-261.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
40. Koo, C., T. L. Innerarity, and R. W. Mahley. 1985. Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J. Biol. Chem. 260: 11934-11943.
41. Werb, Z., and J. R. Chin. 1983. Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J. Biol. Chem. 97: 1113-1118.
42. Carr, T. P., C. J. Andresen, and L. L. Rudel. 1993. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42.
43. Barenghi, L., S. Bradamante, G. A. Giudici, and C. Vergani. 1990. NMR analysis of low-density lipoprotein oxidatively-modified in vitro. Free Radical Res. Comm. 8: 175-183.
44. Brown, M. S., S. K. Basu, J. R. Falck, Y. K. Ho, and J. L. Goldstein. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J. Supramol. Struct. 13: 67-81.
45. Pearson, A. M., A. Rich, and M. Krieger. 1993. Polynucleotide binding to macrophage scavenger receptor depends on the formation of base-quartet-stabilized four-stranded helices. J. Biol. Chem. 268: 3546-3554.
46. deRijke, Y. B., E. M. A. J. Hessels, and T. J. C. vanBerkel. 1992. Recognition sites on rat liver cells for oxidatively modified β-very low density lipoproteins. Arterioscler. Thromb. 12: 41-49.
47. Hazen, S. L., F. F. Hsu, D. M. Mueller, J. R. Crowley, and J. W. Heinecke. 1996. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98: 1283-1289.
48. Keidar, S., M. Kaplan, M. Rosenblat, G. J. Brook, and M. Aviram. 1992. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL. Metabolism. 41: 1185-1192.
49. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-262.
50. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
51. Mohr, D., and R. Stocker. 1994. Radical-mediated oxidation of isolated human very-low-density lipoprotein. Arterioscler. Thromb. 14: 1186-1192.
52. Esterbauer, H., M. Dieber-Rotheneder, G. Waeg, G. Striegl, and G. Jurgens. 1990. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3: 77-92.
53. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jurgens. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13: 341-390.
54. Esterbauer, H., H. Puhl, M. Dieber-Rotheneder, G. Waeg, and H. Rabl. 1991. Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23: 573-581.
55. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acarl. Sci. USA. 81: 3883-3887.
56. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 4: 915-924.
57. Jurgens, G., A. Ashy, and H. Esterbauer. 1990. Detection of new epitopes formed upon oxidation of low density lipoprotein, lipoprotein [a] and very low density lipoprotein. Biochem. J. 265: 605-608.
58. Lavy, A., G. J. Brook, G. Dankner, A. B. Amotz, and M. Aviram. 1991. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism. 40: 794-799.
59. Mohan, P. F., and D. Desaiah. 1994. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages. Biochem. Biophys. Res. Commun. 3: 1047-1054.
60. Parthasarathy, S., M. T. Quinn, D. C. Schwenke, T. E. Carew, and D. Steinberg. 1989. Oxidative modification of beta-very low density lipoprotein: potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 9: 398-404.
61. Horrigan, S., J. H. Campbell, and G. R. Campbell. 1991. Oxidation of beta-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Arterioscler. Thromb. 11: 279-289.
62. Haratz, D., O. Stein, R. Shwartz, E. M. Berry, and Y. Stein. 1988. Preferential metabolism by macrophages of conditioned rabbit hypercholesterolemic remnant lipoproteins. Biochim. Biophys. Acta. 959: 127-133.
63. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 3000-3004.
64. Nicoll, A., R. Duffield, and B. Lewis. 1981. Flux of plasma lipoproteins into human arterial intima. Atherosclerosis. 39: 229-242.
65. f 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler. Thromb. 11: 569-577.
66. Maor, I., and M. Aviram. 1994. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesterol ester. J. Lipid Res. 35: 803-819.
67. Obunike, J. C., I. J. Edwards, S. C. Rumsey, L. K. Curtiss, W. D. Wagner, R. J. Deckelbaum, and I. J. Goldberg. 1994. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J. Biol. Chem. 269: 13129-13135.
68. vanBerkel, T. J. C., Y. B. deRijke, and J. K. Kruijt. 1991. Different fate in vivo of oxidatively modified-LDL and acetylated-LDL in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J. Biol. Chem. 266: 2282-2289.
69. Chait, A., and J. W. Heinecke. 1994. Lipoprotein modification: cellular mechanisms. Curr. Opin. Lipidol. 5: 365-370.
70. Heinecke, J. W. 1997. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8: 268-274.